Eshraghian Ahad, Hamidian Jahromi Alireza
Ahad Eshraghian, Department of Internal Medicine, Namazi hospital, Shiraz University of medical sciences, PO Box 71345-1744 Shiraz, Iran.
World J Gastroenterol. 2014 Jul 7;20(25):8102-9. doi: 10.3748/wjg.v20.i25.8102.
Thyroid hormones are totally involved in the regulation of body weight, lipid metabolism, and insulin resistance. Therefore it is anticipated that thyroid hormones may have a role in the pathogenesis of non alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH). In this study, we reviewed the current literature on the association between thyroid dysfunction and NAFLD/NASH. A search for English language medical literature reporting an association between thyroid dysfunction and NAFLD/NASH in humans was conducted across PubMed, ISI Web of Science, and Scopus in August, 2013. Out of 140 studies initially identified through the search, 11 relevant articles were included in the final review. Thyroid dysfunctions in the form of overt or subclinical hypothyroidism are prevalent among patients with NAFLD/NASH. Hypothyroidism appears to be an independent risk factor for NAFLD/NASH in some studies; however, other newly published studies failed to find such an association. The results of the studies on the role of thyroid abnormalities in NAFLD/NASH are inconsistent, and further research is recommended to determine the relationship between hypothyroidism and NAFLD/NASH and the underlying mechanisms.
甲状腺激素完全参与体重调节、脂质代谢和胰岛素抵抗。因此,预计甲状腺激素可能在非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的发病机制中发挥作用。在本研究中,我们回顾了目前关于甲状腺功能障碍与NAFLD/NASH之间关联的文献。2013年8月,我们在PubMed、ISI科学网和Scopus上搜索了报道人类甲状腺功能障碍与NAFLD/NASH之间关联的英文医学文献。在最初通过搜索确定的140项研究中,最终纳入综述的有11篇相关文章。显性或亚临床甲状腺功能减退形式的甲状腺功能障碍在NAFLD/NASH患者中很常见。在一些研究中,甲状腺功能减退似乎是NAFLD/NASH的一个独立危险因素;然而,其他新发表的研究未能发现这种关联。关于甲状腺异常在NAFLD/NASH中作用的研究结果并不一致,建议进一步研究以确定甲状腺功能减退与NAFLD/NASH之间的关系及其潜在机制。